GlassScriptPhysician profile
Fernando V Ona
NPI 1811934748
$3,095.04
in general payments reported to CMS, 2019-2025
17 companies · $535 in 2025
The $535 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $38.99 · 2021: $266 · 2022: $878 · 2023: $418 · 2024: $415 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $567.18 | 2020-2022 | |
| Genzyme Corporation | $306.52 | 2022-2024 | |
| Intercept Pharmaceuticals, INC. | $295.92 | 2022-2024 | Ocaliva |
| Janssen Biotech, INC. | $284.99 | 2025 | Tremfya |
| Allergan, INC. | $254.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $243.90 | 2021-2023 | Zeposia |
| Pfizer INC. | $234.83 | 2019 | |
| Orphalan INC | $141.72 | 2024 | Cuvrior |
| Ferring Pharmaceuticals INC. | $131.47 | 2023 | Rebyota |
| Exact Sciences Corporation | $124.89 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $124.89 | 2025 | |
| Ardelyx, INC. | $119.93 | 2023 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $113.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.83 | 2019 | |
| Medtronic, INC. | $49.91 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $24.84 | 2021 | |
| Ironwood Pharmaceuticals, INC | $22.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Ona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.